strictly private and...

Q3 2015 STRICTLY PRIVATE AND CONFIDENTIAL

2015 STRICTLY PRIVATE AND CONFIDENTIAL

1 QUARTERLY TECH REPORT – 2015 ANNUAL REVIEW: HEALTHTECH

A MARKET-LEADING CORPORATE FINANCE ADVISORY FIRM… …WITH GLOBAL REACH

•

•

•

•

•

•

DEEP DOMAIN EXPERTISE IN THREE INTER-RELATED SECTORS… …AND BROAD INDUSTRY NETWORKS

http://www.google.co.uk/url?sa=i&source=images&cd=&cad=rja&docid=DFQYiv0ak9F7FM&tbnid=JC0hUqObSsXtIM:&ved=0CAgQjRwwAA&url=http://miranda.hemscott.com/servlet/HsPublic?context=ir.access&ir_option=RNS_NEWS&item=45709189634603&ir_client_id=687&ei=XFtMUracJemM7QaDtIHgCg&psig=AFQjCNEyyjGJ5RmA-3O_m4xWlR5jBhRVwA&ust=1380822236675855

http://www.google.co.uk/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&docid=Xnpv6mT1mXrNHM&tbnid=3pJvLIYwfhFInM:&ved=0CAUQjRw&url=http://my.opera.com/community/opera/buttons/&ei=NuDXUv-XB8am0QXpzoGIBw&bvm=bv.59568121,d.bGE&psig=AFQjCNE6m80XE3hdbm-4Akuss3EvthcY7Q&ust=1389965726223087

http://www.covance.com/index.php

http://www.google.co.uk/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&docid=c0RRud0PBBv66M&tbnid=_v7sGUY1JN5xDM:&ved=0CAUQjRw&url=http://weijiblog.com/2010/03/42-merck/&ei=sEjUUdHsIcSJhQfd_ICgDw&bvm=bv.48705608,d.ZG4&psig=AFQjCNH22HylAPJvqj1KeOfdNdZOwjzjUQ&ust=1372953090294243


LAST

12 M

ON

TH S

HA

RE P

RIC

E P

ER

FO

RM

AN

CE

Q4 2015 PERFORMANCE

3 QUARTERLY TECH REPORT – 2015 ANNUAL REVIEW: HEALTHTECH LA

ST

12 M

ON

THS

Q4 2

015

HEALTHCARE IT - EUROPE HEALTHCARE IT - US BIOPHARMA IT


COMPANY IPO

DATE DESCRIPTION

RAISED ($M)

INDICATIVE PRICE RANGE ($)

IPO LISTING PRICE ($)

INCREASE VS. RANGE

DAY 1 INCREASE

CURRENT INCREASE(1)

CURRENT EV ($M)

EV / REVENUE 2015E

EV / EBITDA 2015E


REVENUE GROWTH (2015-16E) EV / REVENUE 2015E

EBITDA MARGIN 2015E EV / EBITDA 2015E

6

TOTA

L D

ISC

LOSED

DEA

L V

ALU

E (

$M

)

NU

MB

ER

OF D

EA

LS

QUARTERLY TECH REPORT – 2015 ANNUAL REVIEW: HEALTHTECH


DATE BUYER TARGET EV ($M) EV/REVENUE EV/EBITDA COMPANY DESCRIPTION TARGET

LOCATION


DATE COMPANY TYPE OF ROUND

FUNDS RAISED ($M)

INVESTOR PARTICIPATION COMPANY DESCRIPTION COMPANY LOCATION

11

OPERATING METRICS VALUATION METRICS

PRICE % OF 52 MARKET TOTAL NET ENTERPRISE REVENUE REV. GROWTH GROSS MARGIN REVENUE EBITDA

COMPANY (31-DEC-15) WEEK HIGH CAP CASH DEBT VALUE CY2015 CY15-16 HISTORICAL CY2015 CY2016 CY2015 CY2016 CY2015 CY2016

GENERALISTS WITH SIGNIFICANT HEALTHTECH EXPOSURE

HEALTHCARE IT - EUROPE

HEALTHCARE IT - US

BIOPHARMA IT

EBITDA MARGIN

QUARTERLY TECH REPORT – 2015 ANNUAL REVIEW: HEALTHTECH


MANAGER - LONDON PARTNER – NEW YORK PARTNER – LONDON PARTNER – NEW YORK PARTNER – APAC

mailto:[email protected]








































strictly private and...

Documents